tiprankstipranks
Trending News
More News >
Sadhana Nitro Chem Limited (IN:SADHNANIQ)
:SADHNANIQ
India Market
Advertisement

Sadhana Nitro Chem Limited (SADHNANIQ) AI Stock Analysis

Compare
1 Followers

Top Page

IN:SADHNANIQ

Sadhana Nitro Chem Limited

(SADHNANIQ)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
₹8.00
▲(12.83% Upside)
The overall stock score is primarily influenced by financial performance challenges, including inconsistent profitability and cash flow management. Technical analysis indicates bearish momentum, further impacting the score. Valuation concerns with a high P/E ratio suggest potential overvaluation, contributing to a moderate overall score.

Sadhana Nitro Chem Limited (SADHNANIQ) vs. iShares MSCI India ETF (INDA)

Sadhana Nitro Chem Limited Business Overview & Revenue Model

Company DescriptionSadhana Nitro Chem Ltd. engages in manufacturing chemical intermediates, heavy organic and performance chemicals, and wireless network equipment and services. It operates under the Domestic Sales and Export Sales segments. The company was founded by Dhankumar T. Javeri on July 21, 1973 and is headquartered in Mumbai, India.
How the Company Makes MoneySadhana Nitro Chem Limited generates revenue through the manufacturing and sale of its specialty chemicals, primarily nitro compounds, which are essential for various applications in the pharmaceutical and agrochemical industries. The company's revenue model is based on direct sales to industrial clients, where it leverages long-term contracts and relationships to secure consistent demand. Key revenue streams include the production of specialized chemical intermediates used in drug formulations and agricultural products. Additionally, the company may engage in strategic partnerships with other manufacturers and suppliers to enhance its product offerings and expand its market reach, which contributes to its overall earnings.

Sadhana Nitro Chem Limited Financial Statement Overview

Summary
Sadhana Nitro Chem Limited shows revenue growth and operational stability, but faces challenges with profitability consistency and cash flow management. Rising debt levels and high capital expenditures are areas of concern, requiring careful financial strategy to sustain growth and improve cash flow.
Income Statement
72
Positive
The company has shown revenue growth over the years, with a slight dip in the most recent year. Gross profit margins are strong, but net profit margins have been fluctuating, indicating some volatility in profitability. EBIT and EBITDA margins are consistent, showing a stable core operational performance.
Balance Sheet
68
Positive
The debt-to-equity ratio has increased over time, suggesting rising leverage, which could pose risks if not managed carefully. However, the company has maintained a reasonable equity ratio, indicating a solid capital structure. Return on equity has been inconsistent, reflecting fluctuating profitability.
Cash Flow
60
Neutral
Operating cash flow has improved recently, turning positive after periods of cash flow deficits. However, free cash flow remains negative due to high capital expenditures, which could strain liquidity if not controlled. The operating cash flow to net income ratio is improving, signaling better alignment of cash generation with reported earnings.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.58B1.66B1.89B1.42B1.30B1.01B
Gross Profit882.40M1.03B983.25M689.31M548.97M584.68M
EBITDA407.00M441.90M445.34M211.63M175.08M255.04M
Net Income48.20M75.60M40.82M31.78M62.25M159.25M
Balance Sheet
Total Assets0.006.37B5.32B4.26B3.86B3.04B
Cash, Cash Equivalents and Short-Term Investments89.10M112.10M60.52M70.95M129.67M183.60M
Total Debt0.002.47B2.33B1.39B1.16B872.71M
Total Liabilities-2.81B3.56B3.05B2.00B2.26B1.74B
Stockholders Equity2.81B2.81B2.27B2.26B1.60B1.30B
Cash Flow
Free Cash Flow0.00-457.10M-685.02M-861.17M-457.73M-235.56M
Operating Cash Flow0.00478.70M-144.55M-378.15M-47.02M6.61M
Investing Cash Flow0.00-885.60M-648.60M-527.80M-388.15M-233.58M
Financing Cash Flow0.00246.70M411.80M716.39M455.27M300.63M

Sadhana Nitro Chem Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price7.09
Price Trends
50DMA
9.29
Negative
100DMA
8.67
Negative
200DMA
16.22
Negative
Market Momentum
MACD
-0.64
Positive
RSI
32.77
Neutral
STOCH
17.83
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SADHNANIQ, the sentiment is Negative. The current price of 7.09 is below the 20-day moving average (MA) of 8.53, below the 50-day MA of 9.29, and below the 200-day MA of 16.22, indicating a bearish trend. The MACD of -0.64 indicates Positive momentum. The RSI at 32.77 is Neutral, neither overbought nor oversold. The STOCH value of 17.83 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SADHNANIQ.

Sadhana Nitro Chem Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
₹8.17B21.100.40%-3.77%-9.19%
64
Neutral
₹7.52B26.960.86%44.95%184.17%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
56
Neutral
₹7.51B25.7019.75%845.31%
56
Neutral
₹8.96B35.15-7.67%36.60%
54
Neutral
₹2.43B49.501.43%-15.63%3.19%
37
Underperform
₹624.29M-57.54%-143.22%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SADHNANIQ
Sadhana Nitro Chem Limited
7.09
-43.43
-85.97%
IN:BODALCHEM
Bodal Chemicals Limited
59.61
-16.30
-21.47%
IN:CHEMCON
Chemcon Speciality Chemicals Ltd
237.95
-4.25
-1.75%
IN:DMCC
DMCC Speciality Chemicals Limited
292.30
-13.41
-4.39%
IN:FLEXITUFF
Flexituff Ventures International Limited
18.16
-45.58
-71.51%
IN:INDOBORAX
Indo Borax & Chemicals Limited
253.45
60.31
31.23%

Sadhana Nitro Chem Limited Corporate Events

Sadhana Nitrochem Appoints New Independent Director
Oct 18, 2025

Sadhana Nitrochem Limited has announced the appointment of Mr. Tej Mayur Contractor as a Non-Executive Independent Director for a term of five years, starting from October 18, 2025, to October 17, 2030. This decision, approved by the Board of Directors and pending shareholder approval, is based on the Nomination and Remuneration Committee’s recommendation. The appointment aims to strengthen the company’s governance structure and potentially enhance its strategic direction.

Sadhana Nitrochem Appoints New Independent Director
Oct 18, 2025

Sadhana Nitrochem Limited has announced a change in its board of directors. The company has appointed Mr. Tej Mayur Contractor as a Non-Executive Independent Director for a term of five years, starting from October 18, 2025, subject to shareholder approval. This appointment is based on the recommendation of the Nomination and Remuneration Committee. The inclusion of Mr. Contractor, a businessman, is expected to strengthen the company’s governance and strategic direction.

Sadhana Nitrochem Appoints New Independent Director
Oct 18, 2025

Sadhana Nitrochem Limited has announced a significant change in its management structure with the appointment of Mr. Tej Mayur Contractor as a Non-Executive Independent Director. This decision, approved by the Board of Directors and based on the Nomination and Remuneration Committee’s recommendation, is pending shareholder approval and marks a strategic move for the company as it looks to strengthen its governance and leadership framework.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025